Malignant schwannoma with a rhabdomyoblastic component, a so-called triton tumor. A clinicopathologic study
- 15 September 1986
- Vol. 58 (6), 1350-1356
- https://doi.org/10.1002/1097-0142(19860915)58:6<1350::aid-cncr2820580628>3.0.co;2-9
Abstract
Triton tumors, malignant schwannomas with a rhabdomyoblastic component, are rare. This article reports the clinical course, therapeutic approach, and histopathplogic aspects of three cases. Immunoperoxidase staining for the Schwann' s cell marker S-100 protein and for the skeletal muscle proteins desmin, myosin, and myoglobin proved to be useful for diagnosis. The clinical histories of 24 previously reported cases are analyzed, and the therapeutic possibilities are discussed.This publication has 22 references indexed in Scilit:
- Malignant “triton” tumors: A clinicopathologic and immunohistochemical study of nine casesHuman Pathology, 1984
- Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcomaThe American Journal of Surgical Pathology, 1984
- Childhood rhabdomyosarcoma: Experience of the Children's Solid Tumour GroupBritish Journal of Cancer, 1983
- Neurofibroma with rhabdomyomatous differentiation: Benign ‘Triton’ tumour of the vaginaHistopathology, 1983
- Postirradiation neurofibrosarcomaCancer, 1983
- Malignant mesenchymoma of ulnar nerve: combined sarcoma of nerve sheath and rhabdomyosarcoma.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- Malignant schwannoma of “triton” tumor typeMedical and Pediatric Oncology, 1978
- Congenital neurogenous sarcoma with rhabdomyosarcomatous differentiationJournal of Pediatric Surgery, 1977
- Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “triton” tumors)Cancer, 1973
- Solitary Malignant SchwannomaAnnals of Surgery, 1970